Navigation Links
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel
Date:12/11/2013

ers, has completed enrollment of a phase II trial for late stage cervical dysplasia (CIN 2/3), with efficacy data to be reported mid-year 2014. Inovio plans to enter human phase I/IIa trials next year for HPV-caused cervical and head & neck cancers, the latter the most rapidly growing cancer in men. VGX-3100 is designed to raise immune responses against the E6 and E7 oncogenes associated with HPV types 16 and 18. These oncogenes are responsible for transforming HPV-infected cells into pre-cancerous and cancerous cells. The goal is to stimulate a T-cell immune response strong enough to cause the rejection of these infected or transformed cells from the body. VGX-3100 was recognized as the most promising research at the 2011 Global Vaccine Congress, winning first prize in the Edward Jenner Award Competition; it was also recognized by the Vaccine Industry Excellence Awards for "Best Therapeutic Vaccine" in 2013. Best-in-class T cell data from our phase I study was highlighted in a paper published in Science Translational Medicine.

About Inovio Pharmaceuticals, Inc.

Inovio is revolutionizing vaccines to prevent and treat today's cancers and challenging infectious diseases. Its SynCon® vaccines, in combination with its proprietary electroporation delivery, are generating best-in-class immune responses, with therapeutic T-cell responses exceeding other technologies in terms of magnitude, breadth, and response rate. Human data to date have shown a favorable safety profile. Inovio's lead vaccine, a therapeutic against HPV-caused pre-cancers and cancers, is in phase II. Other phase I and preclinical programs target prostate, breast, and lung cancers as well as HIV, influenza, malaria and hepatitis. Partners and collaborators include Roche, the University of Pennsylvania, Merck, NIH, HIV Vaccines Trial Network, National Cancer Institute,
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Doctors at St. Josephs Hospital Stopping Atrial Fibrillation Cold
2. Joseph Rogers Joins SRI International as Executive Director of New Health Sciences Section in Biosciences Division
3. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
4. St. Josephs Hospital Expands Advanced Center for Robotic Surgery in Tampa, Adds Single Site Surgery for Gallbladder Removal
5. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
6. Alliqua Appoints Dr. Joseph Laudano as Vice President of Medical Affairs to Support the Market Expansion of Alliquas SilverSeal Products and Future Clinical Development
7. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
8. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
9. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
10. AdvaMed & BioOhio Discuss MedTech Impact on Ohios Economy, Job Creation
11. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... 4, 2015 Adding SIR-Spheres® ... with unresectable metastatic colorectal cancer in the liver ... Patients with unresectable metastatic colorectal cancer ... experienced the greatest improvement in Progression-Free Survival (PFS) ... Y-90 resin microspheres to a current first-line chemotherapy ...
(Date:7/3/2015)... Mexique, July 3, 2015 ... les épidémies que sont l,hypertension, le diabète et ... de plateformes éducatives gratuites et d,une conférence majeure ... http://photos.prnewswire.com/prnh/20150630/227033 ) , Les ... ligne , Prendre en charge l,hypertension en ...
(Date:7/3/2015)... Redwood Pharma AB has entered ... operating in both the US and China ... supramolecular hydrogel technology in its lead chronic Dry ... The Broda technology offers many unique competitive benefits. At ... and with low concentrations of polymer the system can ...
Breaking Medicine Technology:New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2
... S.C., March 28 Dr. Roger Kenneth,Hershline PhD MD, ... of the not-for-profit public charity CureHIV.us, announces today,that he ... funding from their,Grand Challenges in Global Health initiative. The ... new drug and treatment method, LiSAVIOR., This unique ...
... vector VRX1023 Shows Promising Results, GAITHERSBURG, Md., ... data for VRX1023 today at the Keystone Symposia,Conference ... new vaccine approach --,using HIV-based lentivector as vector ... produced positive results in mice and in,preliminary non-human ...
Cached Medicine Technology:CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR 2VIRxSYS Presents Data on HIV Vaccine at Keystone HIV Vaccine Symposia 2
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, ... of technical sales expertise from the North American Board of Certified Energy Practitioners ... the most highly respected and well established national certification organization for renewable energy ...
(Date:7/3/2015)... , ... July 03, 2015 ... ... the sessions and speaker lineup for its 2015 Annual Conference , ... August 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. ... been retained to lead a national chief nursing officer recruitment for ... firms in the healthcare industry, B. E. Smith has recently placed more than ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is ... Room , the largest network of independent freestanding emergency rooms in the United States. ... of our Sienna Plantation facility,” said Executive Medical Director of First Choice Emergency Room, ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Every year, ... 24-Hour Train-a-Thon where they provide members of the Red Deer community with free fitness ... day of fitness training, games, food, events and entertainment raised thousands of charity dollars ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3
... may extend or shorten life, study finds , THURSDAY, ... to longer survival for ovarian cancer patients, U.S. researchers ... incident epithelial ovarian cancer, the researchers found that higher ... and healthy grain consumption were associated with longer survival. ...
... ... ... ... ...
... Boston, MA Researchers from the Harvard School of Public ... of collaborators have observed for the first time that the ... infection with the Epstein-Barr virus (EBV). This finding implicates EBV ... in an advance online edition of the journal Annals of ...
... ... ... ... ...
... ... ... , ... , , , , ...
... EEG study conducted on college students at American ... mode network, a suggested natural "ground state" of the ... This three-month randomized control study is published in a ... dedicated to the Neuroscience of Meditation and Consciousness, Volume ...
Cached Medicine News:Health News:Pre-Diagnosis Diet Linked to Ovarian Cancer Survival 2Health News:Anthera Pharmaceuticals Completes Initial Public Offering 2Health News:Anthera Pharmaceuticals Completes Initial Public Offering 3Health News:Anthera Pharmaceuticals Completes Initial Public Offering 4Health News:Anthera Pharmaceuticals Completes Initial Public Offering 5Health News:Anthera Pharmaceuticals Completes Initial Public Offering 6Health News:Researchers find further evidence linking Epstein-Barr virus and risk of multiple sclerosis 2Health News:Psoriasis is More Than Skin Deep 2Health News:Psoriasis is More Than Skin Deep 3Health News:Psoriasis is More Than Skin Deep 4Health News:Psoriasis is More Than Skin Deep 5Health News:Psoriasis is More Than Skin Deep 6Health News:Psoriasis is More Than Skin Deep 7Health News:Psoriasis is More Than Skin Deep 8Health News:Founder and President of BOMF, Anne Mahlum, Speaks on How Running Helps to Tackle Homelessness, at National Press Club 2Health News:Transcendental Meditation activates default mode network, the brain's natural ground state 2
Anti-RSV IgA Assay (ELISA)....
... SAS RSV antigen test is ... for the presumptive qualitative detection ... from nasopharyngeal specimens in neonatal ... 15 minute test has a ...
One step Immunochromatographic Assay for the detection of Respiratory Syncytial Virus...
Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
Medicine Products: